These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 9002492

  • 1. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
    Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP.
    JAMA; ; 277(4):301-6. PubMed ID: 9002492
    [Abstract] [Full Text] [Related]

  • 2. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
    Pittet D, Tarara D, Wenzel RP.
    JAMA; 1994 May 25; 271(20):1598-601. PubMed ID: 8182812
    [Abstract] [Full Text] [Related]

  • 3. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.
    Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL.
    JAMA; 1994 May 25; 277(4):307-11. PubMed ID: 9002493
    [Abstract] [Full Text] [Related]

  • 4. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
    Primo MG, Guilarde AO, Martelli CM, Batista LJ, Turchi MD.
    Braz J Infect Dis; 2012 May 25; 16(6):503-9. PubMed ID: 23158266
    [Abstract] [Full Text] [Related]

  • 5. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay.
    Oderda GM, Said Q, Evans RS, Stoddard GJ, Lloyd J, Jackson K, Rublee D, Samore MH.
    Ann Pharmacother; 2007 Mar 25; 41(3):400-6. PubMed ID: 17341537
    [Abstract] [Full Text] [Related]

  • 6. Using a hospital information system to assess the effects of adverse drug events.
    Evans RS, Classen DC, Stevens LE, Pestotnik SL, Gardner RM, Lloyd JF, Burke JP.
    Proc Annu Symp Comput Appl Med Care; 1993 Mar 25; ():161-5. PubMed ID: 8130454
    [Abstract] [Full Text] [Related]

  • 7. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
    Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ.
    Crit Care Med; 2006 Aug 25; 34(8):2084-9. PubMed ID: 16763511
    [Abstract] [Full Text] [Related]

  • 8. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
    Nuckols TK, Paddock SM, Bower AG, Rothschild JM, Fairbanks RJ, Carlson B, Panzer RJ, Hilborne LH.
    Med Care; 2008 Jan 25; 46(1):17-24. PubMed ID: 18162851
    [Abstract] [Full Text] [Related]

  • 9. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.
    Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ.
    Infect Control Hosp Epidemiol; 1999 Nov 25; 20(11):725-30. PubMed ID: 10580621
    [Abstract] [Full Text] [Related]

  • 10. Computerized surveillance of adverse drug events in hospital patients.
    Classen DC, Pestotnik SL, Evans RS, Burke JP.
    JAMA; 1991 Nov 27; 266(20):2847-51. PubMed ID: 1942452
    [Abstract] [Full Text] [Related]

  • 11. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
    Orsi GB, Di Stefano L, Noah N.
    Infect Control Hosp Epidemiol; 2002 Apr 27; 23(4):190-7. PubMed ID: 12002233
    [Abstract] [Full Text] [Related]

  • 12. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
    Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ.
    Crit Care Med; 2003 May 27; 31(5):1312-7. PubMed ID: 12771596
    [Abstract] [Full Text] [Related]

  • 13. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
    Roberts RR, Scott RD, Hota B, Kampe LM, Abbasi F, Schabowski S, Ahmad I, Ciavarella GG, Cordell R, Solomon SL, Hagtvedt R, Weinstein RA.
    Med Care; 2010 Nov 27; 48(11):1026-35. PubMed ID: 20940650
    [Abstract] [Full Text] [Related]

  • 14. Hospital costs, length of stay and mortality attributable to invasive scedosporiosis in haematology patients.
    Heng SC, Slavin MA, Chen SC, Heath CH, Nguyen Q, Billah B, Nation RL, Kong DC.
    J Antimicrob Chemother; 2012 Sep 27; 67(9):2274-82. PubMed ID: 22643193
    [Abstract] [Full Text] [Related]

  • 15. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.
    Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM.
    Infect Control Hosp Epidemiol; 2005 Jun 27; 26(6):540-7. PubMed ID: 16018429
    [Abstract] [Full Text] [Related]

  • 16. Costs of adverse drug events in German hospitals--a microcosting study.
    Rottenkolber D, Hasford J, Stausberg J.
    Value Health; 2012 Jun 27; 15(6):868-75. PubMed ID: 22999137
    [Abstract] [Full Text] [Related]

  • 17. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.
    Kim T, Oh PI, Simor AE.
    Infect Control Hosp Epidemiol; 2001 Feb 27; 22(2):99-104. PubMed ID: 11232886
    [Abstract] [Full Text] [Related]

  • 18. Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients.
    Sheng WH, Chie WC, Chen YC, Hung CC, Wang JT, Chang SC.
    J Formos Med Assoc; 2005 May 27; 104(5):318-26. PubMed ID: 15959598
    [Abstract] [Full Text] [Related]

  • 19. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.
    Digiovine B, Chenoweth C, Watts C, Higgins M.
    Am J Respir Crit Care Med; 1999 Sep 27; 160(3):976-81. PubMed ID: 10471627
    [Abstract] [Full Text] [Related]

  • 20. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL, Ruscin JM.
    Am J Geriatr Pharmacother; 2006 Dec 27; 4(4):297-305. PubMed ID: 17296535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.